Cited by 51Extracellular vesicles in diseaseMolecular Biology Techniques and ApplicationsAdvanced biosensing and bioanalysis techniques

Analysis of Extracellular RNA by Digital PCR

Open access
Takahashi, Kenji, Yan, Irene K., Kim, Chaeyoung, Kim, Jungsu, Patel, Tushar·2014·Frontiers in Oncology

Abstract

The transfer of extracellular RNA is emerging as an important mechanism for inter-cellular communication. The ability for the transfer of functionally active RNA molecules from one cell to another within vesicles such as exosomes enables a cell to modulate cellular signaling and biological processes within recipient cells. The study of extracellular RNA requires sensitive methods for the detection of these molecules. In this methods article, we will describe protocols for the detection of such extracellular RNA using sensitive detection technologies such as digital PCR. These protocols should be valuable to researchers interested in the role and contribution of extracellular RNA to tumor cell biology.

AI snapshot

Written from the paper’s full text.

TL;DR

This methods article describes protocols for isolating extracellular vesicles and RNA and for detecting extracellular RNA by droplet digital PCR (ddPCR) and RainDrop dPCR. It demonstrates sensitive absolute quantification of synthetic and endogenous microRNAs and lncRNAs, including detection below qPCR limits.

Key findings

  • dPCR detected synthetic cel-miR-39 input RNA amounts as low as 0.01 pg.
  • In HepG2 cells and their EVs, miR-29 concentration in EV was 0.6 copies/μl and was decreased compared with donor cells; based on 12 copies of miR-29 per 1 ng cDNA, the authors estimate a minimum of 1.4 copies of miR-29 per 10^6 vesicles on average.
  • TUC339 was not detected in EV derived from human serum by TaqMan RT-qPCR but could be detected by ddPCR with input RNA amounts as low as 0.5 ng/μl (data not shown).
  • dPCR provides absolute quantification and is more tolerant to PCR inhibitors because it uses presence/absence endpoint detection.

Methods

  • EV were isolated from cell culture supernatants or human serum by sequential centrifugation/ultracentrifugation; RNA was extracted using TRIzol or ExoQuick/SeraMir, then reverse transcribed.
  • Two dPCR platforms were used: Bio-Rad QX100 ddPCR and RainDance RainDrop; samples were partitioned into droplets, endpoint PCR was performed, fluorescence was measured, and data were analyzed with QuantaSoft or RainDrop Analyst.
  • The Poisson equation was used for absolute quantification: copies per droplet = −ln(1 − p), where p = fraction of positive droplets. Samples included synthetic cel-miR-39, HepG2 cells and their EVs, and human serum EV RNA analyzed for lncRNA 21A, NDM29, and TUC339.

Limitations

  • The paper states that limited sample size and low abundance of extracellular RNA necessitate a sensitive method such as dPCR, and that further development and standardization of dPCR-based assays are required; digital MIQE guidelines are cited as a first step.
  • The paper states that EV preparations vary with the isolation approach and may contain non-vesicular RNA or restricted EV populations, and that isolation of pure exosomes or other vesicle populations requires additional procedures such as density gradient centrifugation.
  • Evident from the text: no formal limitations section is included; some TUC339 detection data are “not shown,” and several analyses use small replicate numbers (e.g., n = 4 replicates in Figure 4). The paper also notes that dPCR may underestimate true concentration because a positive droplet cannot differentiate the number of molecules present, which is addressed by Poisson correction.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3389/fonc.2014.00129

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

10 of 13 cited sources checked · 7 supported · 0 flagged · accuracy not yet measured

  • Premisecitation

    Recent studies comparing qPCR and dPCR reported improved precision and reproducibility with dPCR.

    “Recent studies have compared the two technologies and reported improved precision and reproducibility with dPCR (11).”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [11] Hindson, 2013, Absolute quantification by droplet digital PCR versus analog real-time PCR, Nat Methods source
  • Premisecitation

    Extracellular RNA is susceptible to degradation by circulating RNAses.

    “Extracellular RNA is susceptible to degradation by circulating RNAses (2).”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [2] Turchinovich, 2011, Characterization of extracellular circulating microRNA, Nucleic Acids Res source

      The Results section (‘Extracellular versus intracellular miRNA expression pattern’; page unavailable) reports that synthetic RNA added to conditioned medium was immediately degraded, supporting susceptibility of unprotected extracellular RNA. But it also reports that endogenous extracellular miRNAs resisted added RNase A; the paper does not establish that extracellular RNA generally is degraded by circulating RNases. (LLM, conf=0.85)

      Experimental — accuracy not yet measured
  • Premisecitation

    Digital PCR provides an alternative approach for detecting gene expression when the amount of target RNA is low and approaching the limits of sensitivity of qPCR.

    “Digital polymerase chain reaction (dPCR) provides an alternative approach for the detection of gene expression in the setting where the amount of target RNA is low and approaching the limits of sensitivity of qPCR (10).”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [10] Hindson, 2011, High-throughput droplet digital PCR system for absolute quantitation of DNA copy number, Anal Chem source

      The Abstract says the droplet digital PCR system provides greater sensitivity than real-time PCR, and Results and Discussion reports detection of rare mutant DNA below the real-time PCR detection limit. The paper's examples concern DNA, however; these passages do not establish its use for detecting gene expression when target RNA is scarce. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
  • Findingown data

    Based on the measured 12 copies of miR-29 per 1 ng of cDNA, there is a minimum of 1.4 copies of miR-29 per 106 vesicles on average.

    “Based on the measured 12 copies of miR-29 per 1 ng of cDNA, we estimate a minimum of 1.4 copies of miR-29 per 106 vesicles on average.”
    Quote in the paperSubstantial claim
  • Findingown data

    dPCR can detect input RNA amounts as low as 0.01 pg.

    “These studies demonstrate the ability of dPCR to detect input RNA amounts as low as 0.01 pg.”
    Quote in the paperSubstantial claim
  • May combine two claims. 12
  • Classified as probably not a substantial claim. 21
  • May combine two claims.

    Premisecitation

    Extracellular vesicles can transfer RNAs such as non-coding RNAs from one cell to another and thereby contribute to inter-cellular communication.

    “Recent studies have confirmed that EV can transfer RNAs such as ncRNAs from one cell to another and thereby contribute to important roles in inter-cellular communication (3–9).”
    • Also stated in: § Abstract · plain
      “The transfer of extracellular RNA is emerging as an important mechanism for inter-cellular communication.”
    • Also stated in: § Introduction · plain
      “An emerging mechanism for cell-to-cell communication involves the transfer of biologically active RNA molecules released into the extracellular space and that can be taken up by recipient cells.”
    Quote in the paperSubstantial claim5 of 7 sources checked
    • cites [3] Vickers, 2012, Lipid-based carriers of microRNAs and intercellular communication, Curr Opin Lipidol source
    • cites [4] Valadi, 2007, Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells, Nat Cell Biol source
    • cites [5] Skog, 2008, Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers, Nat Cell Biol source
    • cites [6] Thery, 2011, Exosomes: secreted vesicles and intercellular communications, F1000 Biol Rep source

      The Introduction reports that exosomes contain mRNA and microRNA and that, in vitro, some exosomal mRNA was translated in target cells, suggesting transfer of genetic information. The RNA and miRNA in secreted membrane vesicles section confirms miRNA in vesicle preparations but does not establish its transfer to recipient cells; the claim is therefore stronger than this source supports for non-coding RNA. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
    • cites [7] Cocucci, 2009, Shedding microvesicles: artefacts no more, Trends Cell Biol source
    • cites [8] Kogure, 2011, Intercellular nanovesicle-mediated microRNA transfer: a mechanism of environmental modulation of hepatocellular cancer cell growth, Hepatology source
    • cites [9] Takahashi, 2014, Long non-coding RNA in liver diseases source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Guidelines for digital MIQE have been proposed.

    “As a first step toward this, guidelines for digital MIQE have been proposed (16).”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [16] Huggett, 2013, The digital MIQE guidelines: minimum information for publication of quantitative digital PCR experiments, Clin Chem source
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    miR-29 can regulate expression of MEG3, a tumor suppressive lncRNA, and miR-29 expression is down regulated in human HCC cells.

    “miR-29 can regulate expression of MEG3, a tumor suppressive lncRNA, and miR-29 expression was down regulated in human HCC cells (14).”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [14] Braconi, 2011, microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer, Oncogene source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data

    RNA yield from 1 ml of human serum was 183 ng.

    “RNA yield was determined using Nanodrop and a total of 183 ng RNA was obtained.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    TUC339 was not detected in EV derived from human serum by TaqMan RT-qPCR, but could be detected by ddPCR with input RNA amounts as low as 0.5 ng/μl.

    “TUC339 was not detected in EV derived from human serum by TaqMan RT-qPCR, but could be detected by ddPCR with input RNA amounts as low as 0.5 ng/μl (data not shown).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Although expression of miR-29b was very low in EV, its detection was possible with ddPCR.

    “Although the expression of miR-29b expression was very low in EV, their detection was possible with ddPCR.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The concentration of miR-29 in EV was 0.6 copies/μl, and was decreased compared with that in donor cells.

    “The concentration of miR-29 in EV was 0.6 copies/μl, and was decreased compared with that in donor cells (Figure 3).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S4 (based).

    Interpretationreasoning

    RNA enclosed within extracellular vesicles may be protected from degradation by circulating RNAses.

    “However, RNA enclosed within EV may be protected from such degradation.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Premisereasoning

    Detection using dPCR is more tolerant to PCR inhibitors because it is based on detection of presence or absence of a reaction end-point.

    “In addition, detection using dPCR is more tolerant to PCR inhibitors because it is based on the detection of presence or absence of a reaction end-point.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisereasoning

    dPCR offers absolute quantification of gene expression, thereby avoiding reliance on invariant genes.

    “dPCR offers the ability to obtain absolute quantification of gene expression, thereby avoiding reliance on the need for invariant genes (which may not be possible in the analysis of extracellular RNA).”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    TUC339 is a long non-coding RNA that is selectively released in EV from hepatocellular cancer cells and is implicated in modulating tumor cell behavior.

    “We also analyzed expression of TUC339, a long non-coding RNA that is selectively released in EV from hepatocellular cancer cells and is foundationally implicated in modulating tumor cell behavior (15).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [15] Kogure, 2013, Extracellular vesicle-mediated transfer of a novel long noncoding RNA TUC339: a mechanism of intercellular signaling in human hepatocellular cancer, Genes Cancer source
  • Probably not a substantial claim: may not pass S2 (checkable).

    Interpretationreasoning

    Due to limited sample size and low abundance of extracellular RNA, a sensitive method of measuring gene expression such as dPCR is necessary.

    “Due to limited sample size and low abundance of extracellular RNA, a sensitive method of measuring gene expression such as dPCR is necessary.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductnone given

    The sequential centrifugation method provides intact EV that can be further analyzed using nanoparticle tracking analysis or electron microscopy.

    “This method provides intact EV that can be further analyzed using nanoparticle tracking analysis (NanoSight LM10 instrument, Amesbury, UK, or similar) or examined with electron microscopy.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable). May combine two claims.

    Interpretationnone given

    For human cancers, tumor-specific changes in EV RNA content could be potentially used, but such applications require sensitive and accurate determination of their RNA content.

    “For human cancers, tumor-specific changes in EV RNA content could be potentially used, but such applications require sensitive and accurate determination of their RNA content.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisenone given

    Increasing the number of partitions offers the potential to increase sensitivity for detecting very small amounts of targets.

    “Increasing the number of partitions offers the potential to increase sensitivity for the detection of very small amounts of targets, and can be accomplished through microfluidic based PCR platforms such as the BioMark (Fluidigm) and Open Array (Life Technologies).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S4 (based).

    Premisenone given

    The ability to detect circulating tumor cell derived extracellular RNA is necessary to enable their use as biomarkers of disease.

    “The ability to detect circulating tumor cell derived extracellular RNA is necessary to enable their use as biomarkers of disease.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable), S4 (based).

    Premisenone given

    The ability to analyze extracellular RNA is essential for the potential application of extracellular RNA as biomarkers for early diagnosis or as prognostic markers of disease.

    “The ability to analyze extracellular RNA is essential for the potential application of extracellular RNA as biomarkers for early diagnosis, or as prognostic markers of disease.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable).

    Interpretationreasoning

    The use of dPCR could be a very useful tool for the detection and quantitation of extracellular RNA.

    “Therefore, the use of dPCR could be a very useful tool for the detection and quantitation of extracellular RNA.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductreasoning

    EV preparations obtained vary with the isolation approach used and may contain non-vesicular RNA or restricted EV populations.

    “It should be noted that the EV preparations obtained vary with the approach used for isolation and depending on the isolation approach used, they may contain non-vesicular RNA or restricted EV populations.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    Gating in the RainDrop assay was performed on a negative control sample and applied for all samples from the same experiment.

    “Gating is performed on negative control sample and applied for all samples from the same experiment.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S4 (based).

    Premisenone given

    dPCR provides absolute quantification.

    “In addition, dPCR provides absolute quantification.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable).

    Interpretationreasoning

    The use of dPCR could be a very useful tool for the detection and quantitation of RNA biomarkers in the clinic.

    “The use of dPCR could be a very useful tool for the detection and quantitation of RNA biomarkers in the clinic.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Interpretationnone given

    The approaches described may provide a dPCR based method that could be used for detecting the presence and for quantitating circulating RNA, or RNA within EV released from cells in culture.

    “The approaches described herein may provide a dPCR based method that could be used for detecting the presence and for quantitating circulating RNA, or RNA within EV released from cells in culture.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    Thresholds for detection in ddPCR were set manually based on results from negative control wells containing water instead of RNA.

    “The data is analyzed using the QuantaSoft software (Bio-Rad) with the thresholds for detection set manually based on results from negative control wells containing water instead of RNA.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductreasoning

    For most isolations, EV were collected from supernatants obtained from at least 16 10-cm culture dishes in order to obtain a sufficient yield for downstream studies.

    “For most isolations, we have collected EV from supernatants obtained from at least 16 10-cm culture dishes in order to obtain a sufficient yield for downstream studies.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Interpretationreasoning

    dPCR has an advantage for studies where the target of interest is limited or present in low quantities that cannot reliably be detected using qPCR.

    “dPCR has an advantage for studies where the target of interest is limited or present in low quantities that cannot reliably be detected using qPCR.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationreasoning

    The use of dPCR offers high sensitivity and enables absolute quantitation of low abundance transcripts that may be present within EV.

    “The use of dPCR offers high sensitivity and enables absolute quantitation of low abundance transcripts that may be present within EV.”
    Quote in the paperSubstantial claim
27 of 27
  • The paper relies on this without support.

    Extracellular RNA can be released from cells as native RNAs, associated with proteins, or enclosed within extracellular vesicles such as exosomes.

    “Extracellular RNA can be released from cells as native RNAs, associated with proteins, or enclosed within extracellular vesicles (EV) such as exosomes.”
  • The paper relies on this without support.

    Extracellular RNA can be detected within extracellular vesicles in the circulation.

    “Extracellular RNA can be detected within EV in the circulation.”
  • The paper relies on this without support.

    dPCR has been shown to provide precise estimates of DNA copy number with high-throughput capabilities.

    “In other applications, dPCR has been shown to be able to provide precise estimates of DNA copy number with high-throughput capabilities.”
3 of 3

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • HepG2 EV preparation methods differ between results and figure caption

    Major

    The results say the HepG2 EV were isolated by differential ultracentrifugation and their RNA isolated as described above, whereas the Figure 3 caption identifies ExoQuick and SeraMir for the EV RNA preparation.

  • Serum RNA used for reverse transcription exceeds the reported yield

    Major

    The results report a total yield of 183 ng RNA from the serum sample, but the Figure 4 caption says 200 ng RNA was used for reverse transcription of that sample.

2 of 2

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Takahashi, K., Yan, I. K., Kim, C., Kim, J., & Patel, T.
Affiliations
Mayo Clinic in Florida (US)
Corresponding author
Patel, Tushar
Venue
Frontiers in Oncology
Published
2014-06-04
Volume
4
Pages
129-129
ISSN
2234-943X (ISSN-L)
OpenAlex
W2171278955
Cited by
51
References
16
Citations by year
2026: 2 · 2025: 4 · 2024: 1 · 2023: 3 · 2022: 1 · 2021: 15 · 2020: 5 · 2019: 3 · 2018: 3 · 2017: 1 · 2016: 6 · 2015: 7
FWCI
1.70
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Frontiers in Oncology (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (submittedVersion, cc-by)
  • PubMed Central (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Institutes of Health (UH2TR000884)
  • NIH Office of the Director (UH2TR000884)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK-069370, R01DK069370)
  • National Center for Advancing Translational Sciences (UH2 TR000884)
  • Common Fund
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Molecular Biology Techniques and Applications
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced biosensing and bioanalysis techniques
Keywords
extracellular RNA, digital PCR, exosomes, intercellular communication, RNA detection, cancer cell biology, extracellular vesicles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-17.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-17.

Cited sources are checked by gpt-6-sol.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review